Innoviva, Inc.
INVANASDAQHealthcare● Active
$22.33
$-0.19(-0.84%)
Market Cap$1.6B
P/E Ratio—
52W High$25.15
52W Low$16.52
Innoviva, Inc. (INVA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · INVA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.43B | $0.36B | $0.31B | $0.33B | $0.39B |
| Cost of Revenue | $0.12B | $0.04B | $0.04B | $0.01B | $0.00B |
| Gross Profit | $0.31B | $0.32B | $0.27B | $0.32B | $0.39B |
| Gross Margin %(computed) | 72.33% | 89.80% | 86.27% | 95.84% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.03B | $0.01B | $0.03B | $0.04B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.06B | $0.02B |
| Total Operating Expenses | $0.14B | $0.16B | $0.15B | $0.11B | $0.02B |
| Operating Income | $0.16B | $0.17B | $0.11B | $0.21B | $0.38B |
| Operating Margin %(computed) | 38.52% | 46.52% | 36.68% | 62.47% | 95.72% |
| Interest Income | $0.02B | $0.02B | $0.02B | $0.01B | $0.00B |
| Interest Expense | $0.02B | $0.02B | $0.02B | $0.02B | $0.02B |
| Income Before Tax | $0.33B | $0.04B | $0.19B | $0.29B | $0.45B |
| Income Tax Expense | $0.06B | $0.01B | $0.01B | $0.07B | $0.08B |
| Net Income | $0.27B | $0.02B | $0.18B | $0.21B | $0.27B |
| Net Margin %(computed) | 63.78% | 6.52% | 57.89% | 64.56% | 67.84% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $4.02 | $0.37 | $2.92 | $3.07 | $3.24 |
| Wtd Avg Shares | 0.07B | 0.06B | 0.07B | 0.07B | 0.08B |
| EBITDA | $0.38B | $0.09B | $0.24B | $0.31B | $0.46B |
| EBITDA Margin %(computed) | 90.28% | 23.84% | 75.71% | 93.05% | 118.50% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Innoviva, Inc. data
About Innoviva, Inc. (INVA) Income Statement
Innoviva, Inc. (INVA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, INVA reported revenue of $0.43B, gross profit of $0.31B (gross margin 72.33%), and net income of $0.27B — a net profit margin of 63.78%.
Frequently asked questions
INVA · 4 questionsInnoviva, Inc. (INVA) reported revenue of $0.43B for 2025, up 18.5% year-over-year.
INVA revenueINVA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08